292 related articles for article (PubMed ID: 10648422)
21. Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor.
Imamura R; Miyamoto T; Yoshimoto G; Kamezaki K; Ishikawa F; Henzan H; Kato K; Takase K; Numata A; Nagafuji K; Okamura T; Sata M; Harada M; Inaba S
J Immunol; 2005 Aug; 175(4):2647-54. PubMed ID: 16081841
[TBL] [Abstract][Full Text] [Related]
22. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
Feuring-Buske M; Frankel A; Gerhard B; Hogge D
Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
[TBL] [Abstract][Full Text] [Related]
23. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice.
Yan XQ; Hartley C; McElroy P; Chang A; McCrea C; McNiece I
Blood; 1995 May; 85(9):2303-7. PubMed ID: 7537109
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
[TBL] [Abstract][Full Text] [Related]
26. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
[TBL] [Abstract][Full Text] [Related]
27. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
[TBL] [Abstract][Full Text] [Related]
28. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle.
Wright DE; Cheshier SH; Wagers AJ; Randall TD; Christensen JL; Weissman IL
Blood; 2001 Apr; 97(8):2278-85. PubMed ID: 11290588
[TBL] [Abstract][Full Text] [Related]
29. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
Cashman JD; Lapidot T; Wang JC; Doedens M; Shultz LD; Lansdorp P; Dick JE; Eaves CJ
Blood; 1997 Jun; 89(12):4307-16. PubMed ID: 9192753
[TBL] [Abstract][Full Text] [Related]
30. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
[TBL] [Abstract][Full Text] [Related]
31. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow.
Yahata T; Ando K; Sato T; Miyatake H; Nakamura Y; Muguruma Y; Kato S; Hotta T
Blood; 2003 Apr; 101(8):2905-13. PubMed ID: 12411299
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
33. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
[TBL] [Abstract][Full Text] [Related]
34. Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma.
Jung SH; Yang DH; Ahn JS; Kim YK; Kim HJ; Lee JJ
J Clin Apher; 2014 Dec; 29(6):305-10. PubMed ID: 24764270
[TBL] [Abstract][Full Text] [Related]
35. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
36. Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.
Szumilas P; Barcew K; Baśkiewicz-Masiuk M; Wiszniewska B; Ratajczak MZ; Machaliński B
Cell Prolif; 2005 Feb; 38(1):47-61. PubMed ID: 15679866
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factor.
Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
J Hematother Stem Cell Res; 2002 Jun; 11(3):523-32. PubMed ID: 12183837
[TBL] [Abstract][Full Text] [Related]
38. The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Goan SR; Fichtner I; Just U; Karawajew L; Schultze W; Krause KP; von Harsdorf S; von Schilling C; Herrmann F
Blood; 1995 Jul; 86(1):89-100. PubMed ID: 7540891
[TBL] [Abstract][Full Text] [Related]
39. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
40. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
